ArticleAging clinical and experimental research2026
Diabetes-related foot disease and sarcopenia-related traits: evidence from US and Chinese cohorts and mendelian randomization.
Article in Aging clinical and experimental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of sarcopenic obesity with advanced cardiovascular-kidney-metabolic syndrome and incident cardiovascular disease: a longitudinal and cross-sectional study.Diabetology & metabolic syndrome · 2026Article
- Mechanistic Pathways Linking Type 2 Diabetes Mellitus, Hypertension, and Osteoarthritis to Falls in Older Adults: A Scoping Review.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHigh-quality evidence examining the relationship between diabetes-related foot diseases (DFD) and sarcopenia-related traits (SRTs) remains limited.
aimsTo investigate whether DFD is associated with an increased risk of SRTs.
methodsWe analyzed data from 48,831 participants in the National Health and Nutrition Examination Survey (NHANES) and China Health and Retirement Longitudinal Study (CHARLS). Adjusted logistic regression models were used to assess the cross-sectional association between DFD and SRTs. From the CHARLS, 9,093 participants without baseline SRTs were followed up to examine the longitudinal associations between DFD and SRTs. Generalized linear models were used to evaluate correlations and trend effects. Mendelian randomization (MR) analysis was conducted to explore potential causal relationships.
resultsIn the NHANES cross-sectional analysis, we observed significant associations between DFD and sarcopenia indicators (strength, assistance with walking, rising from a chair, climbing stairs, and falls score, odds ratios [OR]: 2.59, p < 0.001; lean body mass, OR: 3.04, p < 0.001). DFD demonstrated a significant correlation with sarcopenia indicators (Short Physical Performance Battery [SPPB] score, OR:1.71, p < 0.001; grip strength, OR: 2.48, p < 0.001) in the CHARLS (2011) baseline analysis. In the 2015 CHARLS follow-up analysis, DFD remained significantly associated with the SPPB score (relative risk: 1.32, p < 0.05) and grip strength (relative risk: 1.33, p = 0.001). MR findings were consistent with a causal contribution of diabetic neuropathy and diabetic circulatory complications to lower muscle strength and slower gait speed.
conclusionsThis study established DFD as an independent risk factor for SRTs and may accelerate the onset of sarcopenia relative to diabetes mellitus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.